Your news source for longevity topics reviewed!

MetroBiotech

First Look: MetroBiotech is Pioneering NAD Treatments for Aging and Disease

MetroBiotech leads in NAD research, exploring treatments for aging and diseases through innovative clinical trials and drug development.

April 24, 2024

October 16, 2026

A gene-splicing protein reduced frailty progression in aged mice, offering

July 17, 2026

A long-term dasatinib-and-quercetin study in aged mice used proteomics and

July 17, 2026

SRN-901 extends lifespan 33% and reduces frailty by 70%, reshaping

April 29, 2026

A 2026 Nature Biomedical Engineering study shows how old human